E. Rodríguez-García

Frequency of Cognitive Impairment Without Dementia in Patients With Stroke: A Two-Year Follow-Up Study

T. del Ser, Soledad Serrano, J. Domingo, 2007, Stroke.

Anti-JC virus seroprevalence in a Spanish multiple sclerosis cohort JC virus seroprevalence in Spain

V. Meca-Lallana, Y. Aladro, L. Ayuso, 2016, Journal of the Neurological Sciences.

Three-Year Effectiveness of Dimethyl Fumarate in Multiple Sclerosis: A Prospective Multicenter Real-World Study

V. Meca-Lallana, C. Oreja-Guevara, J. P. Cuello, 2020, CNS Drugs.

Poststroke dementia : clinical features and risk factors.

T. del Ser, T. Ser, J. Vivancos, 2000, Stroke.

Verapamil as treatment for refractory status epilepticus secondary to PRES syndrome on a SARS-Cov-2 infected patient

V. Hernando-Requejo, E. Rodríguez-García, J. Lapeña-Motilva, 2020, Seizure.

Impact of fatigue in multiple sclerosis: the Fatigue Impact Scale for Daily Use (D-FIS)

J. Benito-León, P. Martínez-Martín, J. Ruiz‐Martinez, 2007, Multiple sclerosis.

Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish population

V. Meca-Lallana, C. Oreja-Guevara, Y. Aladro, 2020, Journal of Neurology.

Prestroke Dementia

T. del Ser, R. Barba, E. Rodríguez-García, 2001, Cerebrovascular Diseases.